TY - JOUR
T1 - Ophthalmic and clinical factors that predict four-year development and worsening of diabetic retinopathy in type 1 diabetes
AU - Srinivasan, Sangeetha
AU - Dehghani, Cirous
AU - Pritchard, Nicola
AU - Edwards, Katie
AU - Russell, Anthony W.
AU - Malik, Rayaz A.
AU - Efron, Nathan
N1 - Funding Information:
Funding: This work is a part of a larger study designed to investigate longitudinal markers of diabetic peripheral neuropathy, which was supported by Juvenile Diabetes Research Foundation International [grant number 8-2008-362 ]; and the National Health and Medical Research Council (Australia) [grant number 497230 ].
Funding Information:
Funding: This work is a part of a larger study designed to investigate longitudinal markers of diabetic peripheral neuropathy, which was supported by Juvenile Diabetes Research Foundation International [grant number 8-2008-362]; and the National Health and Medical Research Council (Australia) [grant number 497230].
Publisher Copyright:
© 2017 Elsevier Inc.
PY - 2018/1/1
Y1 - 2018/1/1
N2 - Aims To investigate the role of ophthalmic imaging markers – namely retinal thickness measures and corneal nerve morphology – in predicting four-year development and worsening of diabetic retinopathy (DR) in type 1 diabetes (T1DM). Methods 126 eyes of 126 participants with T1DM were examined at baseline and after four years. Diabetic retinopathy (DR) was graded using the Early Treatment Diabetic Retinopathy Study scale. HbA 1c , nephropathy, neuropathy, cardiovascular factors, and retinal thickness using optical coherence tomography (OCT) and corneal nerve fiber length (CNFL) using corneal confocal microscopy at baseline were assessed by univariate and step-wise multiple logistic regression, and their diagnostic capabilities for single and combined measures. Results Four-year development of DR was 19% (13 of 68 without DR at baseline). Worsening of DR was seen in 43% (25 of 58 with DR at baseline). When adjusted for potential confounders, a lower CNFL (AUC = 0.637, p = 0.040, 64% sensitivity and 64% specificity at 14.9 mm/mm 2 cut-off), higher triglycerides (AUC = 0.669, p = 0.012, 64% sensitivity, 62% specificity at 0.85 mmol/L) and an elevated vibration threshold (AUC = 0.708, p = 0.002, 96% sensitivity, 40% specificity at 3.55 Hz) were significant predictors for four-year worsening of DR. Conclusions Reduced CNFL, elevated vibration perception threshold and higher triglycerides can predict future worsening of DR.
AB - Aims To investigate the role of ophthalmic imaging markers – namely retinal thickness measures and corneal nerve morphology – in predicting four-year development and worsening of diabetic retinopathy (DR) in type 1 diabetes (T1DM). Methods 126 eyes of 126 participants with T1DM were examined at baseline and after four years. Diabetic retinopathy (DR) was graded using the Early Treatment Diabetic Retinopathy Study scale. HbA 1c , nephropathy, neuropathy, cardiovascular factors, and retinal thickness using optical coherence tomography (OCT) and corneal nerve fiber length (CNFL) using corneal confocal microscopy at baseline were assessed by univariate and step-wise multiple logistic regression, and their diagnostic capabilities for single and combined measures. Results Four-year development of DR was 19% (13 of 68 without DR at baseline). Worsening of DR was seen in 43% (25 of 58 with DR at baseline). When adjusted for potential confounders, a lower CNFL (AUC = 0.637, p = 0.040, 64% sensitivity and 64% specificity at 14.9 mm/mm 2 cut-off), higher triglycerides (AUC = 0.669, p = 0.012, 64% sensitivity, 62% specificity at 0.85 mmol/L) and an elevated vibration threshold (AUC = 0.708, p = 0.002, 96% sensitivity, 40% specificity at 3.55 Hz) were significant predictors for four-year worsening of DR. Conclusions Reduced CNFL, elevated vibration perception threshold and higher triglycerides can predict future worsening of DR.
KW - Corneal nerve fibre length
KW - Development
KW - Diabetic retinopathy
KW - Retinal thickness
KW - Risk factors
KW - Worsening
UR - http://www.scopus.com/inward/record.url?scp=85032740581&partnerID=8YFLogxK
U2 - 10.1016/j.jdiacomp.2017.09.002
DO - 10.1016/j.jdiacomp.2017.09.002
M3 - Article
C2 - 29097055
AN - SCOPUS:85032740581
SN - 1056-8727
VL - 32
SP - 67
EP - 74
JO - Journal of Diabetes and Its Complications
JF - Journal of Diabetes and Its Complications
IS - 1
ER -